Endologix, Inc.

Founded in 1992, Endologix, Inc. is singularly focused on providing innovative, minimally invasive technologies for aortic disorders. Our current product offering includes a variety of endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA) and are protected by more than 108 patents.Designed around key issues with challenging anatomies, difficult access and aneurysm sealing, Endologix products have been clinically proven in delivering positive patient outcomes. We are uniquely positioned to offer the most comprehensive product portfolio in AAA therapy.Deeply committed to addressing unmet needs in aortic therapies, Endologix continuously strives to bring ground-breaking and effective solutions to physicians and their patients. With a robust pipeline of best-in-class technology, our vision is to provide physicians with the best device for each patient; because when it comes to ensuring patient well being, we are never satisfied with the status quo.

Bank Name Endologix, Inc.
Stock Exchange NASDAQ
Symbol ELGX
Sector Healthcare
Industry Medical/Dental Instruments
Country United States
World Region America
Chairman
CEO Mr. John Onopchenko
Employees 675
Website www.endologix.com
Registered Year 1992

UpdateContent
UpdateContent
UpdateContent